IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 77 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $561,000 | -5.9% | 424,758 | +31.3% | 0.00% | – |
Q1 2018 | $596,000 | -20.8% | 323,617 | -9.2% | 0.00% | – |
Q4 2017 | $753,000 | +116.4% | 356,570 | +128.9% | 0.00% | – |
Q3 2017 | $348,000 | +11.9% | 155,772 | -14.0% | 0.00% | – |
Q2 2017 | $311,000 | -80.0% | 181,161 | -71.2% | 0.00% | – |
Q1 2017 | $1,554,000 | +63.6% | 629,100 | -0.5% | 0.00% | – |
Q4 2016 | $950,000 | +593.4% | 632,556 | +1070.7% | 0.00% | – |
Q3 2016 | $137,000 | +35.6% | 54,030 | -18.4% | 0.00% | – |
Q2 2016 | $101,000 | +31.2% | 66,231 | +69.3% | 0.00% | – |
Q1 2016 | $77,000 | -18.9% | 39,129 | +27.4% | 0.00% | – |
Q4 2015 | $95,000 | -24.6% | 30,724 | -18.2% | 0.00% | – |
Q3 2015 | $126,000 | -61.2% | 37,563 | -57.1% | 0.00% | – |
Q2 2015 | $325,000 | +221.8% | 87,590 | +222.9% | 0.00% | – |
Q1 2015 | $101,000 | -19.2% | 27,129 | -4.3% | 0.00% | – |
Q4 2014 | $125,000 | -49.2% | 28,335 | -73.5% | 0.00% | – |
Q3 2014 | $246,000 | +33.7% | 106,998 | +68.1% | 0.00% | – |
Q2 2014 | $184,000 | +868.4% | 63,637 | +1238.6% | 0.00% | – |
Q1 2014 | $19,000 | -98.7% | 4,754 | -98.5% | 0.00% | -100.0% |
Q4 2013 | $1,517,000 | – | 327,730 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|